Ocean Biomedical provides update on programs in malaria, fibrosis, and multiple cancers August 10, 2023
Charles River Laboratories International, Inc Q2 2023 Earnings Conference Call Insights August 9, 2023
Ocean Biomedical’s share price target averages $18.21 amid continued progress in research programs August 9, 2023